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Bidirectional modulation of hyperalgesia
via the specific control of excitatory and
inhibitory neuronal activity in the ACC
Sukjae Joshua Kang1, Chuljung Kwak2, Jaehyun Lee3, Su-Eon Sim1, Jaehoon Shim1, Taehyuk Choi3,
Graham L. Collingridge4,5,6,7*, Min Zhuo5,6* and Bong-Kiun Kaang2,5*
Abstract
Neurons in the anterior cingulate cortex (ACC) are assumed to play important roles in the perception of nociceptive
signals and the associated emotional responses. However, the neuronal types within the ACC that mediate these
functions are poorly understood. In the present study, we used optogenetic techniques to selectively modulate
excitatory pyramidal neurons and inhibitory interneurons in the ACC and to assess their ability to modulate
peripheral mechanical hypersensitivity in freely moving mice. We found that selective activation of pyramidal
neurons rapidly and acutely reduced nociceptive thresholds and that this effect was occluded in animals made
hypersensitive using Freund's Complete Adjuvant (CFA). Conversely, inhibition of ACC pyramidal neurons rapidly
and acutely reduced hypersensitivity induced by CFA treatment. A similar analgesic effect was induced by activation
of parvalbumin (PV) expressing interneurons, whereas activation of somatostatin (SOM) expressing interneurons had
no effect on pain thresholds. Our results provide direct evidence of the pivotal role of ACC excitatory neurons, and
their regulation by PV expressing interneurons, in nociception.
Background
The role of the anterior cingulate cortex (ACC) in pain
conditions has been consistently demonstrated for the
past several decades [1, 2]. Human brain imaging studies
report responses of the ACC, and related cortical areas,
to acute nociceptive stimuli [3–6]. Moreover, surgical
lesions of the cingulate cortex (cingulotomy) reduced
the unpleasantness of pain [7–10]. Given the important
role of ACC in pain, numerous animal studies have been
performed in this region to reveal the pathways and
molecular mechanism of nociception and chronic pain
[11–13]. For example, lesioning of rat ACC, similar to
human cingulotomy, reduced aversive behavior during
the conditioned place aversion test [14], and escape/
avoidance test [15]. Numerous electrophysiological studies
have also observed increased activation of the ACC in
both acute and chronic pain situations. For example, an
acute nociceptive stimulus in the peripheral region in-
creased firing of ACC pyramidal neurons whereas a brush
stroke had minimal effect [16–18]. Peripheral injury in-
duced long-term potentiation (LTP) of excitatory synaptic
responses in the ACC neurons [19, 20]. Pharmacological
inhibition or genetic deletion of LTP related molecules in
the ACC reduced pain in chronic models [21–24]. Fur-
thermore, using pharmacological manipulations and elec-
trical stimulation within the ACC, it has been shown that
ACC activation can elicit aversive behaviors [25, 26]. Yet,
the spatiotemporal precision of ACC neuronal activity in
pain remains enigmatic and the function of different ACC
neuronal subtypes is controversial.
Optogenetic tools are increasingly being used to identify
the neural circuits underlying various types of behaviors
or to reveal the functions of specific subtypes of cells
[27, 28]. Several cre line mice are available for the select-
ive manipulation of specific cell types [29, 30]. However,
these methods have only just started to be applied to the
understanding of pain pathways. Studies to date have been
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performed in peripheral regions [31], brain stem [32],
medial prefrontal cortex (mPFC) [33–35] and ACC
[36, 37]. The two optogenetic studies in the ACC used
Thy1-ChR2 mice which expresses ChR2 indiscriminately
within excitatory and inhibitory neurons. One group re-
ported that activation of ACC showed anxiodepressive-
like behaviors but no change in pain [36]. However, the
other group observed an alleviation of acute inflammatory
pain [37] which they attributed to the activation of inhibi-
tory interneurons. The reason for these discrepant results
is unknown.
In the present study, we used optogenetics and cre-
expressing mouse lines to, for the first time, specifically
manipulate the activity of excitatory neurons and inter-
neurons within the ACC to establish whether specific neur-
onal subtypes within this brain region can acutely modulate
nociceptive responses. We injected channelrhodopsin-2
(ChR2) or halorhodopsin (eNpHR3.0) carrying adeno-
associated virus (AAV) in CaMKII-cre mice to activate or
inhibit, respectively, the CAMKII-expressing ACC excita-
tory neurons. We also injected ChR2 into PV-cre or
SOM-cre mice to activate specific PV positive or SOM
positive interneurons. We found that activation of ACC
pyramidal neurons decreased the basal mechanical thresh-
old but did not further decrease the level in CFA-treated
mice. In contrast, inhibition of these neurons reversed the
effects of CFA treatment without affecting the basal mech-
anical threshold. Moreover activation of PV-type interneu-
rons, but not SOM-type interneurons, also alleviated the
CFA-induced pain hypersensitivity. These results show
that excitatory neurons within the ACC are both neces-
sary and sufficient for nociceptive processing and that they
are under tight regulation by PV-expressing interneurons.
These results suggest that ACC excitatory neurons are
one of the critical mediators of nociception.
Methods
Animals
Adult (8–12 week old) male CaMKII-, PV- or SOM- cre
mice (Jackson Laboratory) were used. All animals were
housed under a 12 h light/dark cycle with food and water
provided ad libitum. All works were conducted according
to the policy and regulation for the care and use of labora-
tory animals approved by Institutional Animal Care and
Use Committee at Seoul National University.
Stereotaxic virus injection, optic cannula implantation
AAV carrying DIO-ChR2-EYFP, DIO-eNPHR3.0-EYFP
or DIO-EYFP constructs was injected into 6 week-old
CaMKII-cre hetero male mice. PV-cre hetero and SOM-
cre hetero or wild-type littermates (control) were also
injected with AAV-DIO-ChR2-EYFP. Mice were anes-
thetized with an intraperitoneal injection of ketamine-
xylazine (0.1 mg per gram body weight ketamine, 0.01 mg
per gram body weight xylazine) and the head was fixed in
a stereotaxic apparatus (Kopf Instruments, Tujunga, CA,
USA). A small craniotomy was performed and, five holes
were drilled. Two holes were drilled bilaterally between
the hippocampus and cerebellum for screw implantation.
The other three holes were drilled for virus injection and
optic cannula implantation in the ACC. The virus was
delivered using a 10 μl syringe (Hamilton) and a 30 gauge
metal needle. The injection volume and flow rate (0.5 μl at
0.1 μl/min) were controlled by an injection pump (WPI).
Virus was injected into both side of the ACC (anteropos-
terior [AP] + 1.0 mm from bregma, mediolateral [ML] ±
0.35 mm, dorsoventral [DV] −2.2 mm). After injection,
the needle was left for additional 7 min and then was
slowly removed. The optic cannula (MFC_200/230-0.39_
2mm_ZF1.25_FLT, Doric Lenses., Quebec, Canada) was
implanted between the virus injection site (AP + 1.0 mm
from bregma, ML + 0 mm, DV – 1.25 mm). The optic
cannula was then fixed with dental cement.
Behavior
Electrical von Frey system for checking the mechanical
threshold
A pre-test was done 3 weeks after the surgery and CFA
(1:1 mixture with saline) or saline 10 μl was injected in
the hind paw after the test. 3 days later the post-test was
performed. In each test, there were three light ‘off ’ and
two light ‘on’ sessions (off1-on1-off2-on2-off3, 5 min
intersession interval). Paw withdrawal threshold was
measured with the electronic von Frey system. The aver-
ages of three values were calculated as the threshold of
that session. 593 nm light was given continuously in an
intensity of 7–9 mW/cm2. 473 nm light was given at
10 Hz (40 ms pulse) throughout the ‘on’ period for the
CaMKII-cre mice. PV-cre and SOM-cre mice were given
473 nm light in 300 ms pulses with 2 s inter-pulse inter-
vals. An intensity of 20–25 mW/cm2 at fiber tip was used
in all ChR2 experiments.
Open field test
Mice were exposed for 15 min to the open field appar-
atus under dim light. The open field was a square
opaque white box (40 × 40 × 40 cm) in which mice were
monitored with a tracking program (EthoVision 3.1,
Noldus, Netherlands). Light stimulation was given
throughout the experiment.
Electrophysiology
Patch clamp recording
For whole-cell patch clamp recording, 300 μm thick cor-
onal slices of ACC were prepared with a Leica VT-1000S
slicer and incubated in artificial cerebrospinal fluid (aCSF)
at 25 ~ 26 °C for 1 h. The aCSF comprised 124 mM NaCl,
2.5 mM KCl, 1 mM NaH2PO4, 25 mM NaHCO3, 10 mM
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Glucose, 2 mM CaCl2, 2 mM MgSO4 was used for the
incubation and bath solution. The bath solution was oxy-
genated with 95 % CO2, 5 % O2 mixed gas and perfused
2 ml/min at 25 ~ 26 °C (TC-324B, Warner). The slices
were transferred to the recording chamber of a BX51WI
microscope (Olympus) and visualized with a ProgRes
MFcool CCD camera.
For current-clamp recording, the borosilicate glass re-
cording pipettes were filled with internal solution contain-
ing 145 mM K-gluconate, 5 mM NaCl, 0.2 mM EGTA,
10 mM HEPES, 2 mM MgATP, 0.1 mM Na3GTP, 1 mM
MgCl2 (pH 7.2 with KOH, 280 ~ 290 mOsm). For current
injection, pyramidal neurons in layer 2/3 were current
clamped and 20 pA-140 pA depolarizing current was
injected for 10 s while 473 nm light was delivered to the
ACC area using a 300 ms pulse width and 2 s inter-pulse
interval. For pulse train experiments, pyramidal neurons
in layer 2/3 were current clamped and 2 Hz depolarizing
current pulses (80 pA pulse with 200 ms width) were
injected for 90 s. 473 nm light was delivered to the ACC
area using 300 ms pulses with a 2 s inter-pulse interval for
30 s in the middle of the trains.
In-vivo recording
After 3 weeks of recovery, the mice was anesthetized
with urethane (Sigma, 0.13 g/100 g) injection and the
head was fixed in a stereotaxic apparatus (Kopf Instru-
ments, Tujunga, CA, USA). A small craniotomy was per-
formed and two holes were drilled above the ACC on
each side of the brain (AP + 1.0 mm from bregma, ML ±
0.0 mm) and a third was drilled in the cerebellum for
reference. A customized optrode, composed of a tung-
sten electrode (A-M Systems, USA) and optic cannula
(MFC_200/230-0.39_50mm_ZF1.25_FLT, Doric lenses,
USA), was inserted into the ACC for multiunit record-
ing. Neural activity was amplified 1000 fold and digitized
(sampled at 32 kHz, filtered at 600–6000 Hz) using a
Digital Lynx data acquisition system (Neuralynx).
Data analysis
All data are presented as mean ± SEM. Statistical compari-
sons were made using the t-test, one-way and two-way
ANOVA by SigmaPlot 11.0. The post hoc Bonferroni test
was used for further comparison. If the data did not pass
the equal variance test, one way ANOVA was done in
ranks and Dunn’s method was used for post-hoc test. In
all cases, statistical significance was indicated by *p < 0.05.
Results
Discrete cellular population in the ACC and manipulation
of the excitatory neurons
In the present study, we used three cre mouse lines
(CaMKII-, PV-, SOM-cre) for optogenetic manipulation
in the ACC. We performed immunostaining in the ACC
to observe the distribution of these three different mo-
lecular targets. AAV-DIO-EYFP was injected bilaterally
into the ACC of CaMKII-cre mice and PV and SOM
were stained with antibodies (Fig. 1a, Additional file 1:
Figure S1). All three markers were expressed throughout
the ACC but within discrete cellular populations.
We next tested the effectiveness of the rhodopsins in
pyramidal neurons within the ACC. AAV-DIO-eNpHR3.0,
AAV-DIO-ChR2 or AAV-DIO-EYFP were injected into
the ACC of CaMKII-cre mice and multiunit in vivo re-
cording using an optrode was performed 3 weeks later.
Activation of ChR2 with blue (473 nm) light stimulated
the ACC neurons whereas activation of eNpHR3.0 with
yellow (593 nm) light inhibited their activity (Fig. 1b).
Activation of excitatory neurons in the ACC decreases the
mechanical threshold
Throughout our study, we injected AAV-DIO-ChR2,
AAV-DIO-eNpHR3.0 or AAV-DIO-EYFP in the ACC
bilaterally and the optic cannula was implanted in the
middle of the viral injection sites (Fig. 2a). We first tested
whether specific activation of ACC excitatory neurons is
itself sufficient to modulate the nociceptive responses.
To address this question, AAV-DIO-ChR2 was injected
into the ACC of CaMKII-cre mice (CaMKII-ChR2) and
473 nm light was pulsed at 10 Hz throughout the ‘ON’
period for ACC activation. This frequency was selected
according to the previous in vivo whole-cell patch record-
ing data in the ACC during noxious stimulation [16].
Interestingly, the mechanical threshold of the majority
(10/18) of the mice decreased when the light was given
and fully recovered back to the baseline value when the
light was turned off (Fig. 2b, d). This effect was replicated
when a second period of light excitation was employed
(Fig. 2b, d). In contrast, the AAV-DIO-EYFP injected con-
trol group was invariably unaffected by light (Fig. 2b)
[EYFP (off: 4.99 ± 0.22 g, on: 4.81 ± 0.22 g; n = 10) and
ChR2 (off: 4.90 ± 0.13 g, on: 4.12 ± 0.22 g; n = 18; Fig. 2c)].
The ‘off ’ and ‘on’ sessions were averaged for statistical
analysis and there was a statistically significant interaction
between light (‘off ’ and ‘on’) and virus (‘ChR2’ and ‘EYFP’)
infused (p = 0.011, two-way repeated measures ANOVA).
There was no difference in the patterns of ChR2 expres-
sion between the “decrease” and “non-decrease” groups
(Fig. 2e).
Activation of ACC excitatory neurons has no effect in
chronic pain conditions
To examine the role of ACC excitatory neurons in chronic
pain condition, we used CFA treatment and performed
behavioral experiments as shown schematically in Fig. 3a.
In contrast to the effects of activating ACC excitatory
neurons of CaMKII-ChR2 mice in a non- painful situation
(Before CFA; off: 5.00 ± 0.23 g, on: 4.13 ± 0.40 g; n = 8;
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Fig. 3b black), there was no modification of the mechanical
threshold in the chronic pain state (After CFA; off: 3.25 ±
0.25 g, on: 3.29 ± 0.28 g; n = 8; Fig. 3b red). This suggests an
occlusion of the effects of optogenetic activation of excita-
tory ACC neurons and the effects of inflammatory pain-
induced signals. In the saline injected control group, there
was a similar light-induced reduction in the pain threshold
both before (off: 4.83 ± 0.15 g, on: 4.12 ± 0.25 g; n = 10;
Fig. 3c green) and after saline (off: 4.54 ± 0.11 g, on: 4.08 ±
0.23 g; n = 10; Fig. 3c blue) injection. There was no light
effect in control groups (Additional file 2: Figure S2).
To test the effects of ChR2 activation on locomotion
and anxiety we performed an open field test (OFT). We
found that there were no difference between the CaMKII-
EYFP and CaMKII-ChR2 groups in the OFT when light
was given throughout the experiment. (Additional file
4: Figure S4A). These results identify excitatory ACC
neurons as effectors of pain responses and show that their
activation alone is sufficient for a significant alteration in
the mechanical pain threshold.
Inhibition of excitatory neurons in the ACC reverses the
effects of inflammatory pain
We next inhibited ACC excitatory neurons, expressing
eNpHR3.0 (CaMKII-eNpHR), with yellow light and de-
termined the mechanical threshold before and 3 days
after CFA treatment. Interestingly, optogenetic illumin-
ation had no effect on the mechanical threshold before
CFA injection (off: 4.94 ± 0.22 g, on: 4.90 ± 0.36 g; n = 9)
but after CFA treatment it reversed the mechanical
pain threshold to near control values (3.05 ± 0.19 g,
on: 4.16 ± 0.24 g; n = 9; Fig. 4a). The effect of optoge-
netic illumination was fully reversible and repeatable.
Thus, optogenetic inhibition of excitatory neurons in the
Fig. 1 Distinct cell populations and viral expression of rhodopsins in the ACC of CaMKII-cre mice. a Tissue staining of three different markers in the ACC.
AAV-DIO-EYFP was injected to ACC of CaMKII-cre mice. CaMKII (EYFP), PV and SOM do not co-localize in the ACC. Dotted polygons indicate one side
of ACC. b Optogenetic modulation during multiunit in vivo recording in the ACC of anesthetized mice. 473 nm light stimulated the basal firing of
CaMKII-cre mice injected with AAV-DIO-ChR2-EYFP and 593 nm light inhibited the basal firing of CaMKII-cre mice injected with AAV-DIO-eNpHR-EYFP
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Fig. 2 Activation of CaMKII-positive neurons in the ACC decreases the mechanical threshold. a Schematic diagram of viral injection site (left) and
optic cannula placement (right) in the ACC. b One example of the effects of blue light in a CaMKII-ChR2 expressing mouse (red) and an EYFP
expressing mouse (black) in the von Frey test. c Pooled data for ChR2 and EYFP mice. On average there was a reduction in the mechanical
threshold in the ChR2 group. The graph on the right plots the combined data for the two ON and three OFF episodes. There was a significant
effect of laser light in the ChR2 group: Off: 4.90 ± 0.13 g, on: 4.12 ± 0.22 g; n = 18) but not in the EYFP group (off: 4.99 ± 0.22 g, on: 4.81 ± 0.22 g;
n = 10) [p = 0.011 in virus and light interaction, two-way repeated measures ANOVA]. d Not all animals showed a decrease of the mechanical
threshold during light activation. Out of 18 animals, 10 showed a decrease whilst 8 did not. e The overlapped pattern of ChR2 expression in
each group
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ACC substantially reversed the increase of mechanical
sensitivity in the chronic inflammation pain model (p =
0.011 in drug and light interaction, two-way ANOVA
repeated measures). In contrast, there was no effect of
light in the saline injection group and other control
groups (Fig. 4b, Additional file 3: Figure S3 ). Comparison
of the light ‘ON’ phases for all four groups showed statisti-
cally significant differences between the groups (p <0.001,
one-way ANOVA), such that the EYFP-CFA group was
significantly different from the other groups (Fig. 4c). To
test whether the inhibition affects locomotion and anxiety
we performed the OFT but could not see any differ-
ence between CaMKII-EYFP and CaMKII-eNpHR groups
(Additional file 4: Figure S4B).
To test for the specificity of excitatory neurons within
the ACC for the modulation of the pain threshold, we
examined the effects of light on CaMKII-eNpHR neurons
within the restrospenial cortex (RSG), a region adjacent to
the ACC. In contrast to the ACC, yellow light had no
effect on pain thresholds (Additional file 5: Figure S5).
These result shows that transient inhibition of excitatory
neurons in the ACC can significantly reverse the en-
hanced sensitivity to a mechanical stimulus caused by
inflammation. This suggests, therefore, that excitatory
neurons in the ACC may be effectors of the sensation of
pain.
Optogenetic activation of inhibitory neurons in the ACC
reverses the effects of inflammatory pain
The ACC comprises both excitatory neurons and a di-
verse array of inhibitory neurons that may play distinct
roles in the modulation of pain thresholds. A major class
of GABAergic inhibitory neurons expresses parvalbumin
(PV). We therefore tested whether activation of the ACC
PV-positive interneurons could modulate the mechanical
threshold during chronic inflammation pain. 473 nm light
Fig. 3 Activation of CaMKII-positive neurons in the ACC has no effect on the mechanical threshold in CFA-treated mice. a Schematic of the behavioral
experiment. The pre-test was performed three weeks after the virus infusion and optic cannula implantation. After the pre-test, CFA or saline was
injected into the sole of the right hind paw. The post-test was done three days after the CFA injection. b Effects of blue light in a ChR2 mouse (left)
and pooled data (right) before (black) and after (red) CFA treatment. There was a significant effect of 473 nm laser before CFA (off: 5.00 ± 0.23 g, on:
4.13 ± 0.40 g; n = 8). CFA injection resulted in a lowering of the mechanical threshold and blue light had no effect (off: 3.25 ± 0.25 g, on: 3.29 ± 0.28 g;
n = 8) [p < 0.001 in CFA, p = 0.108 in laser, p = 0.120 in CFA and light interaction, two-way repeated measures ANOVA]. c Equivalent results for the
saline treated group. There was a significant effect in both the pre-test (off: 4.83 ± 0.15 g, on: 4.12 ± 0.25 g; n = 10) and post-test (off: 4.54 ± 0.11 g,
on: 4.08 ± 0.23 g; n = 10) [p = 0.128 in saline, p = 0.027 in laser, p = 0.445 in saline and light interaction]
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was given at 0.5 Hz throughout the ON period, using a
protocol previously applied to the amygdala [30]. We
found that activation of PV-ChR2 expressing neurons
could substantially alleviate CFA-induced pain. In the PV-
ChR2 group there was no significant effect of the 473 nm
light before CFA (off: 5.30 ± 0.15 g, on: 5.04 ± 0.07 g;
n = 6). However, there was significant increase in the
mechanical threshold after CFA injection (off: 3.44 ±
0.11 g, on: 4.55 ± 0.21 g; n = 6; Fig. 5a; p = 0.002 in
CFA and light interaction, two-way repeated measures
ANOVA). Light had no effect in other control groups
(Additional file 6: Figure S6). Since the behavioral
outcome is similar to that of the CaMKII-eNpHR mice,
we wondered whether PV optogenetic activation will in-
hibit excitatory neurons. Current injection and pulse train
tests were performed using whole-cell patch-clamp re-
cording and light was given at 0.5 Hz to mimic the behav-
ioral experiments with the PV-ChR2 mice. In the current
injection experiment, (Fig. 5b, right), excitatory neurons
showed a greater decrease of firing in the light group com-
pared to the control group (Fig. 5b, left). Moreover, in the
pulse train test, the firing of excitatory neurons were re-
duced during the light presentation and recovered when
the illumination was stopped (Fig. 5c). These results dem-
onstrate that optogenetic excitation of PV+ interneurons
inhibits the activity of ACC pyramidal neurons.
In contrast to the effects of activation of PV+ interneu-
rons, there was no effect of the illumination of SOM-
ChR2 expressing neurons on the mechanical threshold
either before (off: 5.11 ± 0.15 g, on: 4.95 ± 0.11 g; n = 12)
or after CFA treatment (off: 3.32 ± 0.16 g, on: 3.30 ±
0.13 g; n = 12; Fig. 5d, Additional file 7: Figure S7). The
whole-cell patch-clamp experiments also showed minimal
effect of optogenetic excitation of SOM+ interneurons on
the activity of ACC pyramidal neurons (Fig. 5e, f ). These
results show that the selective activation of PV+ interneu-
rons, but not SOM+ interneurons, in the ACC is able to
reverse the effects of inflammation on the mechanical pain
threshold, without affecting the mechanical pain threshold
under basal conditions.
Discussion
In the present study, we have demonstrated that neurons
within the ACC are acutely involved in the nociceptive
responses of painful stimuli. We found that the specific
activation of excitatory neurons in the ACC results in a
lowering of the mechanical pain threshold, which is con-
sistent with the view that the ACC is important in noci-
ceptive responses [1, 2, 12, 16]. Interestingly, the effect
occurred rapidly upon optogenetic excitation, was rap-
idly reversible upon termination of illumination and was
reproducible upon a second trial. This strongly suggests
Fig. 4 Inhibition of CaMKII-positive neurons in the ACC alleviates the CFA-induced decrease of the mechanical threshold. a Results of the eNpHR-CFA
group. There was no effect of yellow light before CFA (off: 4.94 ± 0.22 g, on: 4.90 ± 0.36 g; n = 9). However, the mechanical threshold was increased
when light was given after CFA injection (off: 3.05 ± 0.19 g, on: 4.16 ± 0.24 g; n = 9) [p = 0.011 in CFA and laser interaction, two-way repeated measures
ANOVA]. b Result of eNpHR-Saline group. There was no light effect before (4.88 ± 0.21 g, on: 4.71 ± 0.24 g; n = 7) and after saline (off: 4.98 ± 0.23 g,
on: 4.93 ± 0.27 g; n = 7). c Comparison of the post-test light ‘on’ period in all four groups. There was statistically significant difference between groups
(p < 0.001, one-way ANOVA)
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Fig. 5 Activation of PV-positive interneurons in the ACC alleviates the CFA-induced decrease of the mechanical threshold. a Results of the PV-ChR2
CFA group. There was no effect of blue light before (black) CFA (off: 5.30 ± 0.15 g, on: 5.04 ± 0.07 g; n = 6) however, there was significant effect after
(red) CFA injection (off: 3.44 ± 0.11 g, on: 4.55 ± 0.21 g; n = 6) [p = 0.002 in CFA and laser interaction, two-way repeated measures ANOVA]. b Result
of current injection experiment with PV-ChR2 mice. A pyramidal neuron in the ACC was current clamped and current was injected without (left)
and with blue light (right). Blue dots indicate illumination periods. Firing rates of the pyramidal neurons decreased when light was given. c Result
of pulse train experiment with PV-ChR2 mice. A pyramidal neuron in the ACC was current- clamped and current pulses were given for 90 s while
light was given for 30 s as indicated by the blue dots. Firing of the pyramidal neurons decreased as a result of illumination. d Result of the SOM-
ChR2 CFA group. There was no light effect either before (off: 5.11 ± 0.15 g, on: 4.95 ± 0.11 g; n = 12) or after CFA injection (off: 3.32 ± 0.16 g,
on: 3.30 ± 0.13 g; n = 12). e Result of current injection experiment with SOM-ChR2 mice. A pyramidal neuron in the ACC was current-clamped and
current was injected without (left) and with blue light (right). Blue dots indicate light on periods. Light had only a small effect on the firing of pyramidal
neurons. f Result of pulse train experiment with SOM-ChR2 mice. A pyramidal neuron in the ACC was current- clamped and current pulses were given
for 90 s while light was illuminated for 30 s, as the blue dots indicate, but had only a small effect on firing rate
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that these ACC neurons are effectors of the nociceptive
responses as opposed to being a secondary reporter of
the stimulus. This may be due to activating the descend-
ing facilitation projection [38]. Of course, our findings
do not exclude the possibility that there are other pri-
mary mediators of the nociceptive responses. However,
the observation that simply exciting a proportion of
excitatory neurons in the ACC was able to significantly
modify the mechanical pain threshold demonstrates the
key role played by these neurons.
The observation that optogenetic excitation of excita-
tory ACC neurons was unable to further lower the mech-
anical pain threshold in mice treated with CFA suggests
an occlusion between the two effects. In other words, an
increase in activity in these ACC neurons may be mediat-
ing the nociceptive responses of inflammatory pain. If this
is the case, the prediction would be that optogenetic
inhibition of this neuronal may reverse the effects of
inflammation on the mechanical pain threshold. The find-
ing that optogenetic inhibition of excitatory ACC neurons
had a substantial effect on the mechanical threshold
after CFA treatment strongly suggests that these neu-
rons do indeed convey this nociceptive signal. Interest-
ingly, optogenetic inhibition of these neurons had no
effect under normal (non-inflammatory) conditions. Thus,
an increase in activity of this neuronal population signals
the hyperalgesic state. When considered together these
results imply that excitatory neurons in the ACC are both
necessary and sufficient to mediate sensitization to mech-
anical stimuli.
Excitatory neurons in the cortex are under strong
regulation by GABAergic interneurons. We found that
optogenetic stimulation of one class, PV-containing in-
terneurons, was sufficient to have a substantial effect on
the pain threshold. This effect was again specific for the
inflamed state. Indeed, in all respects, stimulation of this
single interneuron class mimicked the effects of inhibition
of the excitatory neurons within this brain structure. This
observation is consistent with the role of PV+ interneu-
rons as mediators of powerful feed-forward inhibition of
pyramidal neurons [39]. It shows that excitatory ACC
neurons are under powerful influence of this interneur-
onal subclass during painful stimuli and that their specific
activation is sufficient to alleviate mechanical hypersensi-
tivity, presumably by their inhibition of pyramidal neurons
in the ACC. Recently, an opposite conclusion has been
reached with respect to the role of the mPFC, especially
the prelimbic cortex (PL), in the processing of painful
information. Activation of PL excitatory neurons reduced
pain [34], and activation of PV interneurons induced more
pain [35]. Moreover, activation of PL projection to nucleus
accumbens relieved pain [33]. These results highlight how
anatomically distinct cortical regions have discrete roles in
pain processing.
Recently two other studies have used optogenetic ap-
proaches to address specifically the functional roles of the
ACC but they drew different conclusions. In one study it
was reported that optogenetic stimulation of Thy1-ChR2
mice did not affect the mechanical threshold [36] whereas
in the other study it was reported that activation of Thy1-
ChR2 mice resulted in analgesia [37]. Why the two studies
reached different conclusions is unclear, though it may be
due to the use of different Thy1-ChR2 mice lines. There
are several possibilities why our conclusions differs from
the study of Barthas et al. [36]. Firstly, in the Thy1 mouse
there is expression of ChR2 in multiple neuronal types.
Indeed, we found that specific activation of ChR2 in pyr-
amidal neurons and PV+ interneurons had diametrically-
opposed effects. Secondly, in this previous study, optoge-
netic stimulation and the mechanical threshold test were
not performed at the same time. Therefore, this raises the
possibility that chronic activation of ACC excitatory neu-
rons does not affect the mechanical threshold but rather
this requires their acute activation. Our study does,
however, agree with the report of Gu et al. [37], which
attributed the analgesia to the activation of inhibitory
neurons, and extends these findings by identifying PV+
neurons as a critical inhibitory neuronal class.
In the study by Barthas et al. [36] it was reported that
optogenetic stimulation resulted in a long lasting alter-
ations in anxiety and depressive-like behaviors [36]. In the
present study we did not observe any effects of optoge-
netic manipulation on anxiety-like behavior, as assessed
using the open field test. This difference could be ex-
plained by the need for repeated stimulation to elicit
mood-related behaviors and/or because in the Thy1-ChR2
mice mixed cell types are affected.
Conclusions
In conclusion, we have identified two specific neuronal
types within the ACC that are involved in the nociceptive
responses to inflammatory pain. These results raise the
possibility that specifically targeting these neuronal popu-
lations may lead to effective treatments of painful states.
Additional files
Additional file 1: Figure S1. ACC neuronal population. Enlarged image
of stained ACC slice. CaMKII, PV and SOM do not co-localize. (PNG 2291 kb)
Additional file 2: Figure S2. Control data of optogenetic activation on
ACC CaMKII-positive neurons. A, Result of the CaMKII-EYFP-CFA group.
There was no light effect during either the pre-test (off: 5.18 ± 0.17 g,
on: 4.96 ± 0.19 g; n = 7) or the post-test (off: 3.15 ± 0.12 g, on: 3.15 ±
0.14 g; n = 7). There was only statistically significant effect of CFA treatment
per se (p < 0.001, two-way repeated measures ANOVA). B, Result of CaMKII-
EYFP-Saline group. There was no light effect either before (off: 4.77 ± 0.44 g,
on: 4.63 ± 0.44 g; n = 6) or after saline injection (off: 4.96 ± 0.17 g, on:
4.82 ± 0.22 g; n = 6). (PNG 45 kb)
Additional file 3: Figure S3. Control data of optogenetic inhibition on
ACC CaMKII-positive neurons. A, Result of the CaMKII-EYFP-CFA group.
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There was no light effect before (off: 4.77 ± 0.20 g, on: 4.97 ± 0.15 g;
n = 6) or after CFA (off: 2.81 ± 0.22 g, on: 2.90 ± 0.16 g; n = 6). There was
only a statistically significant effect of CFA treatment per se (p < 0.001,
two-way repeated measures ANOVA). B, Result of CaMKII-EYFP-Saline
group. There was no light effect either before (off: 4.44 ± 0.30 g, on:
4.17 ± 0.28 g; n = 5) or after CFA (off: 4.27 ± 0.22 g, on: 4.31 ± 0.24 g;
n = 5). (PNG 42 kb)
Additional file 4: Figure S4. Control experiments for locomotion and
anxiety. A, Results of the CaMKII-EYFP and CaMKII-ChR2 groups in the
open field test (OFT). There was no difference between the two groups
in either locomotion (EYFP: 5824 ± 457.6 cm, n = 8; ChR2: 6207 ± 244.8 cm,
n = 17; p = 0.4273, Unpaired t test) or time spent in the center (EYFP:
9.17 ± 1.85 %, n = 8; ChR2: 11.27 ± 1.68 %, n = 17; p = 0.4559, Unpaired
t test). B, Results of the CaMKII-EYFP and CaMKII-eNpHR groups in
the OFT. There was no difference between the two groups in either
locomotion (EYFP: 6616 ± 278.4 cm, n = 7; eNpHR: 6043 ± 212.9 cm, n = 12;
p = 0.1209, Unpaired t test) or time spent in the center (EYFP: 10.96 ± 2.34 %,
n = 7; eNpHR: 10.15 ± 1.35 %, n = 12; p = 0.7488, Unpaired t test). (PNG 28 kb)
Additional file 5: Figure S5. Optogenetic inhibition of CaMKII-positive
neurons in the retrospenial cortex (RSG). There was no light effect either
before (off: 5.07 ± 0.07 g, on: 5.29 ± 0.18 g; n = 8) or after CFA injection
(off: 3.28 ± 0.13 g, on: 3.38 ± 0.19 g; n = 8). (PNG 21 kb)
Additional file 6: Figure S6. Control data of optogenetic activation of
ACC PV-positive interneurons. A, Result of the PV-ChR2 saline group.
There was no light effect either before (off: 5.09 ± 0.22 g, on: 4.84 ± 0.09 g;
n = 6) or after saline injection (off: 5.18 ± 0.18 g, on: 4.79 ± 0.23 g; n = 6).
B, Result of the WT-ChR2 CFA group. There was no light effect before
(off: 5.18 ± 0.13 g, on: 5.12 ± 0.12 g; n = 8) or after CFA (off: 3.33 ± 0.12 g,
on: 3.58 ± 0.19 g; n = 8). There was only statistically significant effect of CFA
treatment per se (p < 0.001, two-way repeated measures ANOVA). C, Result
of the WT-ChR2 saline group. There was no light effect either before
(off: 4.7 ± 0.15 g, on: 4.93 ± 0.28 g; n = 5) or after saline (off: 4.94 ± 0.15 g,
on: 4.67 ± 0.27 g; n = 5). (PNG 70 kb)
Additional file 7: Figure S7. Control data of optogenetic activation of
ACC SOM-positive interneurons. Result of WT-ChR2 CFA group. There was
no light effect either before (off: 5.15 ± 0.20 g, on: 5.32 ± 0.20 g; n = 6) or
after CFA injection (off: 3.10 ± 0.09 g, on: 3.24 ± 0.07 g; n = 6). (PNG 23 kb)
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